NCT (Nicastrin) Gene

📖 Wiki Page

gene916 wordssynced 2026-04-02

NCT (Nicastrin) Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">NCT — Nicastrin</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>NCT</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Nicastrin</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p31.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/51594" target="_blank">51594</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103546" target="_blank">ENSG00000103546</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprotkb/Q92542" target="_blank">Q92542</a></td>
</tr>
<tr>
<td class="label">Primary Disease Links</td>
<td>[Alzheimer's disease](/diseases/alzheimers), [Parkinson's disease](/diseases/parkinsons-disease)</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

NCT (Nicastrin) Gene

Introduction

Nct (Nicastrin) Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

...

NCT (Nicastrin) Gene

Introduction

Nct (Nicastrin) Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Mermaid diagram (expand to render)

NCT encodes nicastrin, a core membrane glycoprotein of the [gamma-secretase complex](/mechanisms/app-amyloid-pathway-alzheimers). Nicastrin is required for stable assembly and trafficking of [Presenilin-1 (PSEN1)](/genes/psen1), [Presenilin-2 (PSEN2)](/genes/psen2), [APH1](/genes/aph1), and [PEN2](/genes/pen2), and it helps position transmembrane substrates for intramembrane cleavage.[@shah2005][@kaether2006] In [neurons](/entities/neurons) and glia, this complex processes many signaling proteins, most prominently [APP](/genes/app), where cleavage balance influences generation of [amyloid-beta](/proteins/amyloid-beta) peptides relevant to Alzheimer's disease pathogenesis.[@selkoe2016][@szaruga2017]

Gene and Protein Context

The human gene resides on chromosome 1p31.3 and encodes a type I transmembrane glycoprotein with a large ectodomain. Structural work shows nicastrin does not function as a classical protease; instead it acts as a scaffolded substrate-gating partner that contributes to substrate recruitment and quality control of complex assembly.[@shah2005][@zhou2019] Glycosylation of the ectodomain is important for maturation and endosomal-lysosomal trafficking of the active complex, linking nicastrin biology to broader [autophagy-lysosomal pathways](/mechanisms/autophagy-lysosomal-alzheimers).[@sannerud2016]

Mechanistic Role in Gamma-Secretase Biology

[Gamma-secretase](/entities/gamma-secretase) activity depends on correct stoichiometric assembly of all four subunits. Nicastrin promotes maturation of presenilin holoprotein into catalytically active N- and C-terminal fragments and supports transport of assembled complex from ER/Golgi compartments to endosomes and plasma membrane microdomains.[@kaether2006][@sannerud2016] Because [APP](/entities/app-protein) and Notch are both gamma-secretase substrates, NCT influences neuronal proteostasis and cell-fate signaling in parallel.[@de2012]

In APP processing, altered gamma-secretase processivity can shift peptide length distributions, including pathogenic Aβ42 enrichment. Nicastrin state (expression, glycoforms, subcellular localization) modifies this processivity context with presenilin variants, creating an interaction layer between genetic background and amyloid output.[@selkoe2016][@szaruga2017][@chvezgutirrez2012]

Relevance to Alzheimer's Disease

NCT itself is not a common high-penetrance Mendelian AD gene, but convergent human genetic and biochemical data support it as a modifier in amyloidogenic pathways. Experimental reduction of nicastrin expression decreases overall gamma-secretase activity and lowers Aβ generation, while risking mechanism-based toxicity from impaired Notch signaling if inhibition is not substrate-selective.[@de2012][@chvezgutirrez2012] This helped motivate the field shift from broad gamma-secretase inhibitors to modulators that tune cleavage pattern rather than fully block catalytic activity.[@rynearson2018]

Nicastrin is also linked to microglial and astrocytic biology indirectly through APP fragment signaling and inflammatory feed-forward pathways engaging [NF-kappaB](/proteins/nfkb1-protein). In AD tissue and models, this axis may couple amyloid burden to chronic glial activation.[@heneka2014]

Although strongest evidence centers on AD, gamma-secretase substrates also include proteins relevant to synaptic maintenance and axonal function in [Parkinson's disease](/diseases/parkinsons-disease) and [frontotemporal dementia](/diseases/ftd). Dysregulated membrane protein cleavage can perturb endolysosomal flux and mitochondrial stress signaling, pathways repeatedly implicated across PD, DLB, and atypical parkinsonism.[@sannerud2016][@moors2017] This positions NCT as a cross-disease systems node rather than a disease-specific driver gene.

Therapeutic Implications

Current therapeutic logic emphasizes substrate-selective modulation of gamma-secretase or pathway-level combination strategies (for example, pairing amyloid-targeted biologics with upstream processing modulators). NCT biology is central to both strategies because it influences complex stability, substrate presentation, and compartment-specific cleavage behavior.[@chvezgutirrez2012][@rynearson2018] Open translational questions include whether cell-type-selective delivery or context-dependent modulation can reduce Aβ toxicity without Notch-related adverse effects.

Open Research Questions

Which nicastrin conformational states most strongly correlate with pathogenic Aβ42/Aβ40 shifts in human brain tissue?

How does NCT-dependent substrate selection differ between neurons, [astrocytes](/entities/astrocytes), and [microglia](/cell-types/microglia-neuroinflammation) during disease progression?

Can precision modulators of the nicastrin-substrate interface preserve essential Notch signaling while reducing amyloidogenic APP processing?

Background

The study of Nct (Nicastrin) Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Shah S, Lee SF, Tabuchi K, et al, Nicastrin functions as a gamma-secretase-substrate receptor (2005)](https://doi.org/10.1016/j.cell.2005.05.022)

[Kaether C, Haass C, Steiner H, Assembly, trafficking and function of gamma-secretase (2006)](https://doi.org/10.1038/nrn2623)

[Selkoe DJ, Hardy J, The amyloid hypothesis of Alzheimer's disease at 25 years (2016)](https://doi.org/10.1016/S0092-8674(16)

[Szaruga M, Veugelen S, Benurwar M, et al, Alzheimer's-causing mutations shift Aβ length by destabilizing gamma-secretase-Aβn interactions (2017)](https://doi.org/10.1016/j.cell.2017.09.037)

[Zhou R, Yang G, Guo X, et al, Recognition of APP C99 by the active gamma-secretase complex (2019)](https://doi.org/10.1126/science.aaz7611)

[Sannerud R, Declerck I, Peric A, et al, Restricted location of PSEN2/gamma-secretase determines substrate specificity and generates an intracellular Aβ pool (2016)](https://doi.org/10.1016/j.cell.2016.05.020)

[De Strooper B, Iwatsubo T, Wolfe MS, Presenilins and gamma-secretase: structure, function, and role in Alzheimer disease (2012)](https://pubmed.ncbi.nlm.nih.gov/18348958/)

[Chávez-Gutiérrez L, Bammens L, Benilova I, et al, The mechanism of gamma-Secretase dysfunction in familial Alzheimer disease (2012)](https://doi.org/10.1038/nn.3601)

[Rynearson KD, Ponnusamy M, Prikhodko O, et al, Preclinical validation of a potent gamma-secretase modulator for Alzheimer's disease prevention (2018)](https://doi.org/10.1073/pnas.1818456115)

[Heneka MT, Kummer MP, Latz E, Innate immune activation in neurodegenerative disease (2014)](https://doi.org/10.1038/nri3705)

[Moors T, Paciotti S, Chiasserini D, et al, Lysosomal dysfunction and alpha-synuclein aggregation in Parkinson's disease (2017)](https://doi.org/10.1002/mds.27393)

Pathway Diagram

The following diagram shows the key molecular relationships involving NCT (Nicastrin) Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

NCT (Nicastrin) Gene

NCT (Nicastrin) Gene

NCT (Nicastrin) Gene

Introduction

Overview

NCT (Nicastrin) Gene

NCT (Nicastrin) Gene

Introduction

Overview

Gene and Protein Context

Mechanistic Role in Gamma-Secretase Biology

Relevance to Alzheimer's Disease

Relevance to Parkinson's Disease and Related Disorders

Therapeutic Implications

Open Research Questions

See Also

Background

External Links

References

Pathway Diagram